BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 28 filers reported holding BIOLINERX LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $27,000 | -86.2% | 61,205 | -72.7% | 0.00% | – |
| Q2 2018 | $195,000 | 0.0% | 224,399 | 0.0% | 0.00% | – |
| Q1 2018 | $195,000 | -58.9% | 224,399 | -48.4% | 0.00% | -100.0% |
| Q4 2017 | $474,000 | +56.4% | 434,700 | +60.9% | 0.00% | – |
| Q3 2017 | $303,000 | +140.5% | 270,200 | +105.5% | 0.00% | – |
| Q1 2017 | $126,000 | +186.4% | 131,480 | +389.2% | 0.00% | – |
| Q4 2014 | $44,000 | -77.7% | 26,878 | -79.0% | 0.00% | -100.0% |
| Q3 2014 | $197,000 | +116.5% | 128,100 | +193.1% | 0.00% | – |
| Q2 2014 | $91,000 | +51.7% | 43,700 | +63.1% | 0.00% | – |
| Q1 2014 | $60,000 | +106.9% | 26,800 | +162.7% | 0.00% | – |
| Q4 2013 | $29,000 | -78.5% | 10,200 | -83.4% | 0.00% | – |
| Q3 2013 | $135,000 | +181.2% | 61,600 | +106.3% | 0.00% | – |
| Q2 2013 | $48,000 | – | 29,855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Senvest Management, LLC | 3,603,300 | $4,684,000 | 0.35% |
| Broadfin Capital, LLC | 3,500,000 | $4,550,000 | 0.28% |
| Opaleye Management Inc. | 250,000 | $325,000 | 0.14% |
| Benchmark Capital Advisors | 47,000 | $61,000 | 0.05% |
| NEXT Financial Group, Inc | 37,500 | $48,000 | 0.02% |
| MENTA CAPITAL LLC | 88,517 | $115,000 | 0.02% |
| Orbimed Advisors | 1,038,600 | $1,350,000 | 0.01% |
| Alyeska Investment Group, L.P. | 444,738 | $578,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 600,000 | $780,000 | 0.00% |
| Airain ltd | 14,674 | $19,000 | 0.00% |